Hippo Labs are one of only 17 digital health companies selected for this prestigious and exciting programme. The selection process was rigorous and highly competitive, involving expert NHS and industry panel assessments, interviews, and due diligence checks. This year, there were over 160 applicants in the process with successful companies being those with the highest potential to meet London’s NHS and social care challenges.
Now in its seventh year, the DigitalHealth.London Accelerator is funded by Health Innovation Network (HIN) through its Office for Life Sciences funding and its partners, including CW+. In addition, the Accelerator will receive £185k from the UK Government through the UK Shared Prosperity Fund.
DigitalHealth.London’s Accelerator aims to speed up the adoption of technology in London’s NHS, relieving high pressure on services and empowering patients to manage their health. Over the years, the Accelerator has supported over 140 high-potential digital health companies, working with companies over a 12-month period, giving bespoke support and advice, a programme of expert-led workshops and events. The overarching goal is to broker meaningful connections between innovators and NHS organisations with specific challenges.
We are excited to learn from the incredible team at DigitalHealth.London to help us bring outstanding Proactive Care to as many practices and patients as possible.
Sara Nelson, Programme Director, DigitalHealth.London, said: “We are delighted to announce the 17 digital health companies joining our seventh DigitalHealth.London Accelerator cohort. The application process for this year’s programme was extremely competitive and as such, the final 17 companies truly are the ones to watch in the digital health space. We look forward to working with them over the next year to support the NHS and social care through digital transformation.”